For availing the discount please write to us at firstname.lastname@example.org
Genomics is the study of the gene and its functions and proteomics is the study of the structure and functions of proteomes or sets of proteins by using molecular biology and bioinformatics tools and technology. Genomics involves the mapping of genes and DNA sequencing to understand the structure and functions of genomes. A proteome is a complete set of proteins expressed by a genome at a certain time. Proteomics primarily involves the use of molecular biology, biochemistry, and genetics to analyze proteins produced by genes through the translation process. Proteins are the primary component of all cells and are responsible for the various functional characteristics of cells. A defect in the genome or proteome structure or function could result in disorders. Thus, genomics and proteomics technologies play an important role in research, drug discovery, and disease diagnosis, which require the identification and study of the defective genome or proteins. It requires various instruments, reagents, and software for protein isolation, purification, identification, quantification, and analysis of the genome and proteome. There are several analytical instruments used for genomics and proteomics, but the instruments most widely used are chromatography systems, mass spectrometers, Polymerase Chain Reaction systems, and Next-generation Sequencing systems.
TechNavio’s analysts forecast the Global Genomics and Proteomics Analytical Instruments market will grow at a CAGR of 7.83 percent over the period 2013-2018.
Covered in this Report
The Global Genomics and Proteomics Analytical Instruments market can be divided into four segments: Chromatography, Polymerase Chain Reaction, Mass Spectrometry, and Next-generation Sequencing. This report covers the present scenario and the growth prospects of the Global Genomics and Proteomics Analytical Instruments market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of analytical instruments in the above four segments.
TechNavio’s report, the Global Genomics and Proteomics Analytical Instruments Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Genomics and Proteomics Analytical Instruments market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
Other Prominent Vendors
- Becton Dickinson and Co.
- Bruker Corp.
- GE Healthcare
- Jasco Inc.
- Jeol Ltd.
- Luminex Corp.
- Qiagen NV
- Rigaku Corp.
- Shimadzu Corp.
- Sigma Aldrich Co. LLC
- Spectrolab Systems
- Waters Corp.
Key Market Driver
- Advances in Genomics and Proteomics Technology
- For a full, detailed list, view our report.
Key Market Challenge
- Lack of Knowledge of Genomics and Proteomics
- For a full, detailed list, view our report.
Key Market Trend
- Focus on Drug Discovery and Disease Diagnosis
- For a full, detailed list, view our report.
Key Questions Answered in this Report
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Technology
07.1 Global Chromatography Instruments Market
07.1.1 Market Size and Forecast
07.2 Global PCR Instruments Market
07.2.1 Market Size and Forecast
07.3 Global Mass Spectrometry Instruments Market
07.3.1 Market Size and Forecast
07.4 Global NGS Instruments Market
07.4.1 Market Size and Forecast
08. Geographical Segmentation
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Vendor Analysis 2013
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 Agilent Technologies Inc.
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation by Revenue 2013
17.1.4 Business Segmentation by Revenue 2012 and 2013
17.1.5 Sales by Geography
17.1.6 Business Strategy
17.1.7 Key Information
17.1.8 SWOT Analysis
17.2 Bio-Rad Laboratories
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation by Revenue 2012
17.2.4 Business Segmentation by Revenue 2012 and 2011
17.2.5 Geographical Segmentation by Revenue 2012
17.2.6 Business Strategy
17.2.7 Recent Developments
17.2.8 SWOT Analysis
17.3 F. Hoffmann La Roche Ltd.
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation
17.3.4 Business Segmentation by Revenue 2012 and 2013
17.3.5 Sales by Geography
17.3.6 Business Strategy
17.3.7 Key Information
17.3.8 SWOT Analysis
17.4 Illumina Inc.
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation
17.4.4 Sales by Geography
17.4.5 Business Strategy
17.4.6 Key Information
17.4.7 SWOT Analysis
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Segmentation by Revenue 2013
17.5.4 Business Segmentation by Revenue 2012 and 2013
17.5.5 Business Strategy
17.5.6 Key Developments
17.5.7 SWOT Analysis
17.6 Thermo Fisher Scientific Inc.
17.6.1 Key Facts
17.6.2 Business Overview
17.6.3 Business Segmentation by Revenue
17.6.4 Product Segmentation by Revenue
17.6.5 Sales by Geography
17.6.6 Business Strategy
17.6.7 Key Information
17.6.8 SWOT Analysis
18. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Genomics and Proteomics Analytical Instruments Market 2013-2018 (US$ million)
Exhibit 3: Global Genomics and Proteomics Analytical Instruments market by Technology
Exhibit 4: Chromatography : Segmentation by Technology
Exhibit 5: Polymerase Chain Reaction: Segmentation by Technology
Exhibit 6: Mass Spectrometry : Segmentation by Technology
Exhibit 7: Global Genomics and Proteomics Analytical Instruments Market: Segmentation by Technology 2013
Exhibit 8: Global Chromatography Instruments Market 2013-2018 (US$ million)
Exhibit 9: Global PCR Instruments Market 2013-2018 (US$ million)
Exhibit 10: Global Mass Spectrometry Instruments Market 2013-2018 (US$ million)
Exhibit 11: Global NGS Instruments Market 2013-2018 (US$ million)
Exhibit 12: Global Genomics and Proteomics Analytical Instruments Market: Segmentation by Geography 2013
Exhibit 13: Agilent Technologies Inc.: Business Segmentation by Revenue 2013
Exhibit 14: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 15: Agilent Technologies Inc.: Sales by Geography 2013
Exhibit 16: Bio-Rad Laboratories: Business Segmentation by Revenue 2012
Exhibit 17: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)
Exhibit 18: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 19: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 20: F. Hoffmann-La Roche Ltd: Business Segmentation by Revenue 2012 and 2013
Exhibit 21: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 22: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Diagnostics Division)
Exhibit 23: Illumina Inc.: Business Segmentation 2013
Exhibit 24: Illumina Inc.: Sales by Geography 2013
Exhibit 25: PerkinElmer: Business Segmentation by Revenue 2013
Exhibit 26: PerkinElmer: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 27: Thermo Fisher Scientific Inc.: Business Segmentation by Revenue 2013
Exhibit 28: Thermo Fisher Scientific Inc.: Product Segmentation by Revenue 2013
Exhibit 29: Thermo Fisher Scientific Inc.: Sales by Geography 2013
TechNavio Announces the Publication of its Research Report - Global Genomics and Proteomics Analytical Instruments Market 2014-2018
TechNavio recognizes the following companies as the key players in Global Genomics and Proteomics Analytical Instruments Market: Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc. , PerkinElmer Inc., Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Bruker Corp., GE Healthcare, Jasco Inc., Jeol Ltd., Luminex Corp., Qiagen NV, Rigaku Corp., Shimadzu Corp., Sigma Aldrich Co. LLC, Spectrolab Systems, Waters Corp.
Commenting on the report, an analyst from TechNavio’s team said: “Advances in technology encourage extensive focus on drug discovery and disease diagnosis. Genomics and proteomics instruments allow better understanding of genome expression patterns and gene regulation mechanisms. Pharmaceutical and biotechnology companies such as Agilent Technologies, Illumina, and Life Technologies invest in medical research to develop advanced tools and services”
According to the report, the Global Genomics and Proteomics Analytical Instruments market is driven by several factors. One of the major factors driving the market is the advances in genomics and proteomics technology. Because of improved accuracy, sensitivity, specificity, and diagnostic speed, the use of genomics and proteomics tools has increased. Advances in technology drive the demand for innovative and improved data analysis tools and services.
Further, the report states that though the Global Genomics and Proteomics Analytical Instruments market has several drivers, the growth of the market is curtailed by some serious challenges. One of the major challenges in the market is the lack of knowledge of genomics and proteomics among doctors and researchers, which leads to misinterpretation of genetic data
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.